Butabarbital will decrease the extent or impact of fedratinib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Influence of coadministering a strong CYP3A4 inducer with fedratinib has not been researched. Butabarbital, mostly generally known as Butisol commercially, is definitely an approved Agenda III drug while in the https://quentinb427vus5.qodsblog.com/profile